Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Effect of Low-dose Rhythmic 17-β-estradiol Administration on Bone Turnover in Postmenopausal Women
NCT05903820Phase 4Completed
- Sponsor
- University of Amsterdam
- Start
- Jul 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Phase 4, randomised trial of estradiol in osteoporosis and menopause (3 arms), sponsored by University of Amsterdam. Primary endpoint: Serum Procollagen type 1 N-terminal propeptide at 16 weeks. Started Jul 2023; status: completed.
02
Drugs
estradiol
03
Conditions
osteoporosismenopause
Beyond the preview
Go deeper on NCT05903820.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05903820.